Home

RxSight, Inc. - Common Stock (RXST)

8.0000
-0.4600 (-5.44%)
NASDAQ · Last Trade: Jul 12th, 5:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close8.460
Open8.320
Bid8.000
Ask8.200
Day's Range7.850 - 8.497
52 Week Range6.320 - 58.23
Volume2,226,301
Market Cap271.86M
PE Ratio (TTM)-11.94
EPS (TTM)-0.7
Dividend & YieldN/A (N/A)
1 Month Average Volume1,744,374

Chart

About RxSight, Inc. - Common Stock (RXST)

Rxsight Inc is a healthcare technology company that focuses on enhancing vision correction through its innovative approach to personalized refractive surgery. The company develops advanced systems that utilize sophisticated algorithms and proprietary software to optimize intraocular lenses for patients undergoing cataract surgery. By combining data-driven insights with precision eye care, Rxsight aims to improve visual outcomes for patients, ultimately advancing the standards of treatment in the ophthalmic field. Their commitment to personalized medicine is reflected in their ongoing research and development efforts to create more effective solutions for vision-related challenges. Read More

News & Press Releases

Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 11, 2025
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Earnings Scheduled For May 7, 2025benzinga.com
Via Benzinga · May 7, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 9, 2025
Crude Oil Moves Higher; RxSight Shares Plungebenzinga.com
Via Benzinga · July 9, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · July 9, 2025
These stocks are moving in today's sessionchartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 9, 2025
Alphabet To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · July 9, 2025
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In Maybenzinga.com
Via Benzinga · July 9, 2025
Which stocks are gapping on Wednesday?chartmill.com
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · July 9, 2025
These stocks are moving in today's pre-market sessionchartmill.com
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 9, 2025
Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 9, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 9, 2025
Analyst Expectations For RxSight's Futurebenzinga.com
Via Benzinga · July 9, 2025
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via Benzinga · July 9, 2025
RxSight Falls 34% After Hours Following Revenue Warningbenzinga.com
RxSight Inc. (RXST) shares plunged 34.32% in after-hours. The decline to $8.40 follows a downward revision of its 2025 revenue forecast.
Via Benzinga · July 9, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 8, 2025
Wondering what's happening in today's after-hours session?chartmill.com
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 8, 2025
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary financial results for the second quarter 2025 and revised full-year 2025 guidance. The Company will host a conference call on Tuesday, July 8, 2025, at 5:00 p.m. Eastern Time.
By RxSight, Inc. · Via GlobeNewswire · July 8, 2025
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
By RxSight, Inc. · Via GlobeNewswire · May 20, 2025
Gapping stocks in Monday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings)benzinga.com
Via Benzinga · May 19, 2025
Top 3 Health Care Stocks That Are Preparing To Pump This Quarterbenzinga.com
Via Benzinga · May 9, 2025
RxSight, Inc. Reports First Quarter 2025 Financial Results
ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31, 2025.
By RxSight, Inc. · Via GlobeNewswire · May 7, 2025